A standardized framework for the validation and verification of clinical molecular genetic tests
暂无分享,去创建一个
Andrew Wallace | Els Dequeker | Anniek Corveleyn | Michael A Morris | Gert Matthijs | Elfriede Swinnen | Christopher J Mattocks | Clemens R Müller | Victoria Pratt | E. Dequeker | G. Matthijs | C. Mattocks | A. Corveleyn | V. Pratt | M. Morris | E. Swinnen | C. Müller | A. Wallace
[1] Leonard Steinborn,et al. International Organization for Standardization ISO/IEC 17025 General Requirements for the Competence of Testing and Calibration Laboratories , 2004 .
[2] Rn Carey,et al. CLSI/NCCLS: EP15-A2. User verification of performance for precision and trueness , 2006 .
[3] D. M.,et al. Protocols for Determination of Limits of Detection and Limits of Quantitation; Approved Guidelines , 2004 .
[4] Soma Das,et al. Technical Standards and Guidelines: Molecular Genetic Testing for Ultra-Rare Disorders , 2005, Genetics in Medicine.
[5] Bertil Magnusson,et al. Understanding the meaning of accuracy, trueness and precision , 2007 .
[6] Robert Harper,et al. Reporting of precision of estimates for diagnostic accuracy: a review , 1999, BMJ.
[7] E. Prence. A practical guide for the validation of genetic tests. , 1999, Genetic testing.
[8] M. Pruvost,et al. Minimizing DNA contamination by using UNG-coupled quantitative real-time PCR on degraded DNA samples: application to ancient DNA studies. , 2005, BioTechniques.
[9] C. L. Rümke. Uncertainty as to the acceptance or rejection of the presence of an effect in relation to the number of observations in an experiment. , 1968, Triangle; the Sandoz journal of medical science.
[10] Rümke Cl. Uncertainty as to the acceptance or rejection of the presence of an effect in relation to the number of observations in an experiment. , 1968 .
[11] M. Gulley,et al. Recommended principles and practices for validating clinical molecular pathology tests. , 2009, Archives of pathology & laboratory medicine.
[12] Darrell R. Abernethy,et al. Making sense of trueness, precision, accuracy, and uncertainty , 2008 .
[13] S. Carley,et al. An introduction to power and sample size estimation , 2003, Emergency medicine journal : EMJ.
[14] J. Hartley,et al. Dealing with contamination: enzymatic control of carryover contamination in PCR. , 1993, PCR methods and applications.
[15] E. Dequeker,et al. Variability in the use of CE-marked assays for in vitro diagnostics of CFTR gene mutations in European genetic testing laboratories , 2009, European Journal of Human Genetics.
[16] J. Witte,et al. Comparison of missing data approaches in linkage analysis , 2003, BMC Genetics.
[17] David Moher,et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. , 2003, Clinical chemistry.
[18] Lukas Wagner,et al. A Greedy Algorithm for Aligning DNA Sequences , 2000, J. Comput. Biol..
[19] J. Hartley,et al. Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions. , 1990, Gene.
[20] Mano Sivaganesan,et al. A Bayesian method for calculating real-time quantitative PCR calibration curves using absolute plasmid DNA standards , 2008, BMC Bioinformatics.
[21] J A Hanley,et al. If nothing goes wrong, is everything all right? Interpreting zero numerators. , 1983, JAMA.
[22] David Moher,et al. Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative. , 2003, Radiology.